0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Research Letter |

State Vaccination Requirements for HPV and Other Vaccines for Adolescents, 1990-2015 FREE

Jason L. Schwartz, PhD, MBE1; Laurel A. Easterling1
[+] Author Affiliations
1University Center for Human Values, Princeton University, Princeton, New Jersey
JAMA. 2015;314(2):185-186. doi:10.1001/jama.2015.6041.
Text Size: A A A
Published online

Eight years after human papillomavirus (HPV) vaccines were first recommended in the United States, vaccination coverage is substantially below the Healthy People 2020 target of 80%.1 Data from the US Centers for Disease Control and Prevention (CDC) show that 37.6% of adolescent girls and 13.9% of adolescent boys had completed the 3-dose series in 2013.2 Recent efforts to address these deficits emphasize that HPV vaccines should not be viewed or treated differently than other routinely recommended vaccines.1,2

School requirements are a mainstay of US vaccination policy, widely used by states to promote high vaccination rates. Depending on the vaccine, requirements may exist for attendance at day care, preschool, kindergarten, or higher grade levels.3 Attention to their potential value has been largely absent from recent discussions of strategies to improve HPV vaccination rates. However, requirements were extensively discussed following the approval of the first HPV vaccine in 2006.4

Proponents of vaccination argued at that time that requirements would be premature, explaining that a multi-year implementation period focused on supply, safety, financing, and education is warranted before requiring any new vaccine.5,6 We sought to examine the presence and timing of state requirements for vaccines with particular relevance to adolescent health and to compare those findings to the implementation of HPV vaccines.

Vaccines studied were those used by the CDC to evaluate adolescent vaccination (ie, included in the National Immunization Survey—Teen) that were added to the recommended schedule since 1990 and protected against new disease targets: hepatitis B, varicella, meningococcal conjugate, and HPV. Using legal databases, CDC and other publications, and information from health departments, we identified the earliest date that a requirement, if applicable, took effect for each vaccine in every state and the District of Columbia (DC) for any childhood, adolescent, or college-aged population.

Requirements approved through March 2015 were identified, including those with later effective dates. We calculated the time that elapsed between the publication of the corresponding recommendation of the CDC Advisory Committee on Immunization Practices (ACIP) in the Morbidity and Mortality Weekly Report, formalizing a change to the recommended vaccination schedule, and the effective date of each requirement.

Vaccination requirements (Table) were more common for hepatitis B vaccine (47 states and DC), varicella vaccine (50 states and DC), and meningococcal conjugate vaccine (29 states and DC) than for HPV vaccine (2 states and DC). Through March 2015, only Virginia and DC required HPV vaccination, and each includes broad, vaccine-specific exemption procedures. A third requirement will take effect in Rhode Island in August 2015.

Table Graphic Jump LocationTable.  Frequency of State Vaccination Requirements for Selected Childhood and Adolescent Vaccines and Timing Relative to Publication of CDC/ACIP Routine Recommendations, 1990-2015

At the corresponding point in their histories (8 years after publication of a routine ACIP recommendation), hepatitis B vaccine was required in 36 states and DC, varicella vaccine in 38 states and DC, meningococcal conjugate vaccine in 21 states and DC, and HPV vaccine in 1 state and DC.

Vaccination against HPV is currently required in only 2 states, many fewer than another vaccine associated with sexual transmission (hepatitis B) and another primarily recommended for adolescents (meningococcal conjugate). Limitations of this analysis include the lack of differentiation between adolescent-age school requirements for the vaccines studied and requirements for other age groups. Also, historical information regarding requirement timing may have been inaccurately recorded or reported.

Why HPV vaccine requirements have not been more widely implemented is unclear, but may reflect reluctance among states to revisit the contentious political climate surrounding requirement proposals in 2006-2007.4 The novelty of the 3-dose HPV vaccine series in the adolescent schedule may present additional challenges. The recent approval and recommendation of a 9-valent HPV vaccine offers a new opportunity to consider all strategies shown to promote high vaccination rates, including school requirements.

Section Editor: Jody W. Zylke, MD, Deputy Editor.

Corresponding Author: Jason L. Schwartz, PhD, MBE, University Center for Human Values, Princeton University, 5 Ivy Ln, Princeton, NJ 08544 (jlschwar@princeton.edu).

Author Contributions: Dr Schwartz had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Study concept and design: Schwartz.

Acquisition, analysis, or interpretation of data: All authors.

Drafting of the manuscript: Schwartz.

Critical revision of the manuscript for important intellectual content: All authors.

Statistical analysis: Schwartz.

Administrative, technical, or material support: Easterling.

Study supervision: Schwartz.

Conflict of Interest Disclosures: The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.

Curtis  CR, Dorell  C, Yankey  D,  et al; Centers for Disease Control and Prevention (CDC).  National human papillomavirus vaccination coverage among adolescents aged 13-17 years-National Immunization Survey—Teen, United States, 2011. MMWR Surveill Summ. 2014;63(suppl 2):61-70.
PubMed
Elam-Evans  LD, Yankey  D, Jeyarajah  J,  et al; Immunization Services Division, National Center for Immunization and Respiratory Diseases; Centers for Disease Control and Prevention (CDC).  National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years—United States, 2013. MMWR Morb Mortal Wkly Rep. 2014;63(29):625-633.
PubMed
US Centers for Disease Control and Prevention. State vaccination requirements. http://www.cdc.gov/vaccines/imz-managers/laws/state-reqs.html. Accessibility verified June 9, 2015.
Schwartz  JL, Caplan  AL, Faden  RR, Sugarman  J.  Lessons from the failure of human papillomavirus vaccine state requirements. Clin Pharmacol Ther. 2007;82(6):760-763.
PubMed   |  Link to Article
Savage  L.  Proposed HPV vaccine mandates rile health experts across the country. J Natl Cancer Inst. 2007;99(9):665-666.
PubMed   |  Link to Article
Association of Immunization Managers. Position statement: school and child care immunization requirements. http://www.immunizationmanagers.org/resource/resmgr/files/aimpositionstatement.pdf. Accessibility verified June 10, 2015.

Figures

Tables

Table Graphic Jump LocationTable.  Frequency of State Vaccination Requirements for Selected Childhood and Adolescent Vaccines and Timing Relative to Publication of CDC/ACIP Routine Recommendations, 1990-2015

References

Curtis  CR, Dorell  C, Yankey  D,  et al; Centers for Disease Control and Prevention (CDC).  National human papillomavirus vaccination coverage among adolescents aged 13-17 years-National Immunization Survey—Teen, United States, 2011. MMWR Surveill Summ. 2014;63(suppl 2):61-70.
PubMed
Elam-Evans  LD, Yankey  D, Jeyarajah  J,  et al; Immunization Services Division, National Center for Immunization and Respiratory Diseases; Centers for Disease Control and Prevention (CDC).  National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years—United States, 2013. MMWR Morb Mortal Wkly Rep. 2014;63(29):625-633.
PubMed
US Centers for Disease Control and Prevention. State vaccination requirements. http://www.cdc.gov/vaccines/imz-managers/laws/state-reqs.html. Accessibility verified June 9, 2015.
Schwartz  JL, Caplan  AL, Faden  RR, Sugarman  J.  Lessons from the failure of human papillomavirus vaccine state requirements. Clin Pharmacol Ther. 2007;82(6):760-763.
PubMed   |  Link to Article
Savage  L.  Proposed HPV vaccine mandates rile health experts across the country. J Natl Cancer Inst. 2007;99(9):665-666.
PubMed   |  Link to Article
Association of Immunization Managers. Position statement: school and child care immunization requirements. http://www.immunizationmanagers.org/resource/resmgr/files/aimpositionstatement.pdf. Accessibility verified June 10, 2015.
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

2,641 Views
3 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
Jobs